South and Central America Compression Therapy Market is expected to reach US$ 140.5 Million by 2034

According to The Insight Partners research, the South and Central America Compression Therapy Market was valued at US$ 102.7 Million in 2025 and is expected to reach US$ 140.5 Million by 2034, registering a CAGR of 3.6% from 2026 to 2034.

Digital health & remote monitoring integration with compression therapy and decentralized & home based care adoption are among the critical factors attributed to driving the South & Central America compression therapy market growth.

Official digital health strategies, such as the World Health Organization's Global Strategy on Digital Health, emphasize using digital tools to improve health outcomes, support equitable access, and strengthen health systems worldwide, providing a framework that supports digital transformation in medical devices, including compression therapy systems. In parallel, several South American countries are strengthening telehealth policies and digital healthcare programs to improve access to chronic disease management, particularly in underserved and remote areas. Brazil, Chile, and Colombia have expanded regulatory frameworks supporting telemedicine, while public and private healthcare providers are increasingly adopting remote patient monitoring solutions for selected chronic conditions. As reimbursement and digital health infrastructure continue to evolve, connected medical devices that collect and transmit patient data beyond conventional healthcare settings are expected to gain wider acceptance, thereby supporting the future adoption of smart compression therapy technologies.

In compression therapy, these broader digital health currents have driven new smart connected devices that combine compression garments or pneumatic systems with sensors, mobile interfaces, and remote clinician dashboards. For example, FDA-cleared sequential compression devices include Bluetooth connectivity and digital tracking, enabling clinicians to monitor patient adherence and pressure profiles remotely, improving therapy personalization and outcomes. As telehealth and remote patient monitoring become embedded in chronic disease care protocols, compression therapy devices that integrate with these digital ecosystems will see higher adoption, particularly for the long-term management of venous diseases, lymphedema, and post-operative care.

On the contrary, complex regulatory approval and product compliance requirements hamper growth in the South & Central America compression therapy market.

South and Central America Compression Therapy Market Segmentation Analysis:

• By Product, the South and Central America Compression Therapy Market is segmented into Compression Bandages, Compression Wraps, Compression Stockings, Compression Sleeves, Compression Tape, Compression Braces, Compression Pumps, and Others. The Compression Bandages segment is projected to expand at a CAGR of 4.2% during 2026 - 2034.
• By Technology, the South and Central America Compression Therapy Market is segmented into Static Compression Therapy and Dynamic Compression Therapy. The Static Compression Therapy segment is projected to expand at a CAGR of 3.5% during 2026 - 2034.
• By Application, the South and Central America Compression Therapy Market is segmented into Lymphedema, Leg Ulcer, Deep Vein Thrombosis, Varicose Veins, Lipedema, and Others. The Varicose Veins segment is projected to expand at a CAGR of 3.7% during 2026 - 2034.
• By End User, the South and Central America Compression Therapy Market is segmented into Hospitals and Clinics, Nursing Care Centers, Home Care Settings, and Other End Users. The Hospitals and Clinics segment is projected to expand at a CAGR of 4.0% during 2026 - 2034.

By country, the South and Central America Compression Therapy Market is categorized into Brazil, Argentina, and the Rest of South and Central America. Brazil is projected to expand at a CAGR of 4.0% during 2026 - 2034.

Key players operating in the Compression Therapy Market are Arjo AB, Essity AB, Lohmann & Rauscher GmbH & Co KG, Paul Hartmann AG, Convatec Inc, Enovis Corp, Solventum Corporation, Juzo, SIGVARIS GROUP, and medi Canada Inc, among others.

• In Jan 2024, Enovis completed the acquisition of LimaCorporate. The acquisition extends the Company's current footprint to emerging and growing markets, expands its product lines, and strengthens its global innovation platform. Enovis uses its experience and EGX business management system, a comprehensive set of tools and repeatable, teachable processes, to integrate acquisitions and create superior value for its customers, shareholders, and associates.